CYP17A1 and neuroblastoma: In spite of too limited ganglioneuroblastoma (GNB) specimens were acquired, the activation of this AR-SCAP-SREBPs-HMGCR/CYP17A1 axis was specific in NB distinct from other neuroendocrine or neuroblastic tumors.